For the quarterly period ended September 30, 2010 | Commission File No. 1-11083 |
DELAWARE | 04-2695240 | |
(State of Incorporation) | (I.R.S. Employer Identification No.) |
Large accelerated filer þ | Accelerated filer o |
Non-accelerated filer
o
(Do not check if a smaller reporting company) |
Smaller reporting company o |
Shares outstanding | ||
Class | as of October 31, 2010 | |
Common Stock, $.01 par value | 1,520,076,600 |
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
FINANCIAL INFORMATION
Three Months Ended
Nine Months Ended
September 30,
September 30,
in millions, except per share data
2010
2009
2010
2009
$
1,916
$
2,025
$
5,804
$
6,109
623
629
1,939
1,867
1,293
1,396
3,865
4,242
634
665
1,897
1,987
230
258
714
778
39
51
147
149
16
129
126
381
381
1,817
5
65
10
17
(250
)
5
9
98
44
236
523
1,042
1,345
4,869
3,905
251
51
(1,004
)
337
(91
)
(91
)
(286
)
(285
)
3
(4
)
(2
)
(13
)
163
(44
)
(1,292
)
39
(27
)
50
9
(12
)
$
190
$
(94
)
$
(1,301
)
$
51
$
0.13
$
(0.06
)
$
(0.86
)
$
0.03
$
0.12
$
(0.06
)
$
(0.86
)
$
0.03
1,519.8
1,509.3
1,517.0
1,507.0
1,529.3
1,509.3
1,517.0
1,514.4
Table of Contents
Table of Contents
Nine Months Ended
September 30,
(in millions)
2010
2009
$
(124
)
$
1,164
(209
)
(225
)
1
54
(4
)
(4
)
(517
)
(5
)
(41
)
(217
)
(733
)
200
(200
)
973
(900
)
(725
)
28
32
101
(693
)
2
(240
)
(260
)
864
1,641
$
624
$
1,381
$
122
$
111
Table of Contents
Table of Contents
Table of Contents
September 30,
December 31,
(in millions)
2010
2009
$
6,854
$
6,854
2,369
2,384
9,223
9,238
(2,932
)
(2,507
)
$
6,291
$
6,731
Table of Contents
Table of Contents
Table of Contents
Amount of Gain
Amount of Gain
(Loss)
(Loss)
Reclassified from
Amount of Gain (Loss)
Recognized in
AOCI into
Recognized in Earnings on
OCI
Earnings
Ineffective Portion and
(Effective
(Effective
Location in Statement of
Amount Excluded from
Location in Statement of
Cash Flow Hedges
Portion)
Portion)
Operations
Effectiveness Testing*
Operations
Three Months Ended September 30, 2010
$
1
Interest expense
$
(173
)
5
Cost of products sold
$
(173
)
$
6
Three Months Ended September 30, 2009
$
(10
)
$
(11
)
Interest expense
$
(1
)
Interest expense
**
(133
)
(1
)
Cost of products sold
$
(143
)
$
(12
)
$
(1
)
Nine Months Ended September 30, 2010
$
2
Interest expense
$
(56
)
(22
)
Cost of products sold
$
(56
)
$
(20
)
Nine Months Ended September 30, 2009
$
(18
)
$
(31
)
Interest expense
$
(2
)
Interest expense
**
(106
)
23
Cost of products sold
$
(124
)
$
(8
)
$
(2
)
*
**
Amount of Gain (Loss) Recognized
Location
in Earnings
(in millions)
Derivatives Not Designated as
in Statement of
Three Months Ended September 30,
Nine Months Ended September 30,
Hedging Instruments
Operations
2010
2009
2010
2009
Other, net
$
(40
)
$
(41
)
$
(67
)
$
(8
)
Cost of products sold
(1
)
$
(40
)
$
(41
)
$
(67
)
$
(9
)
Table of Contents
September 30,
December 31,
(in millions)
Location in Balance Sheet (1)
2010
2009
Prepaid and other current assets
$
32
$
20
Other long-term assets
21
12
53
32
Prepaid and other current assets
16
24
$
69
$
56
Other current liabilities
$
83
$
64
Other long-term liabilities
64
29
147
93
Other current liabilities
55
17
$
202
$
110
(1)
Table of Contents
(in millions)
Level 1
Level 2
Level 3
Total
$
310
$
310
$
69
69
$
310
$
69
$
379
$
202
$
202
$
202
$
202
Table of Contents
September 30,
December 31,
(in millions)
2010
2009
$
652
$
671
94
69
177
180
$
923
$
920
September 30,
December 31,
(in millions)
2010
2009
$
3,145
$
3,266
(1,433)
(1,538)
$
1,712
$
1,728
September 30,
December 31,
(in millions)
2010
2009
$
413
$
1,453
439
472
752
684
$
1,604
$
2,609
September 30,
December 31,
(in millions)
2010
2009
$
927
$
857
149
863
102
111
258
233
$
1,436
$
2,064
Table of Contents
2010
2009
$
55
$
62
12
21
(22
)
(28
)
$
45
$
55
Payments due by Period
(in millions)
2010
2011
2012
2013
2014
Thereafter
Total
$
100
$
200
$
700
$
1,000
850
$
600
$
3,600
5,050
$
950
$
200
$
700
$
600
$
3,600
$
6,050
Note:
Table of Contents
Current
Actual as of
Requirement
September 30, 2010
3.85 times
2.6 times
3.0 times
5.7 times
(1)
(2)
Table of Contents
Table of Contents
Total estimated amount expected to
Type of cost
be incurred
$205 million to $207 million
$31 million
$65 million
$66 million
$16 million to $18 million
$42 million to $48 million
$425 million to $435 million
(1)
(2)
Table of Contents
Total estimated amount expected to
Type of cost
be incurred
$30 million to $35 million
$20 million to $25 million
$85 million to $90 million
$135 million to $150 million
(1)
Total estimated amount expected
to be incurred
$110 million to $115 million
$5 million to $10 million
$45 million to $50 million
$20 million to $25 million
$180 million to $200 million
(1)
(2)
Table of Contents
Table of Contents
Table of Contents
2010
Plant
2007
Restructuring
Network
Restructuring
Plan
Optimization
Plan
Total
$
61
$
26
$
205
$
292
8
31
39
20
65
85
89
26
301
416
66
66
12
16
28
32
41
73
3
3
3
44
123
170
$
92
$
70
$
424
$
586
2010
Plant
2007
Restructuring
Network
Restructuring
Plan
Optimization
Plan
Total
$
19
$
19
$
8
$
2
10
3
3
$
22
$
8
$
2
$
32
$
33
$
12
$
45
2
2
$
20
12
32
15
3
18
$
48
$
20
$
29
$
97
$
33
$
191
$
224
66
66
$
32
41
73
15
64
79
$
48
$
32
$
362
$
442
Table of Contents
Plant
Network
2010 Restructuring Plan
Optimization
2007 Restructuring Plan
Termination
Termination
Termination
Benefits
Other
Subtotal
Benefits
Benefits
Other
Subtotal
Total
$
158
$
10
$
168
$
168
(23
)
(8
)
(31
)
(31
)
135
2
137
137
34
34
68
68
(128
)
(35
)
(163
)
(163
)
41
1
42
42
$
22
12
17
29
51
(28
)
(18
)
(46
)
(46
)
22
25
-
25
47
$
61
$
20
$
81
4
4
4
8
93
(3
)
(3
)
(3
)
(33
)
(15
)
(48
)
(12
)
(3
)
(15
)
(63
)
$
28
$
5
$
33
$
26
$
14
$
1
$
15
$
74
Three Months Ended
Nine Months Ended
September 30,
September 30,
2010
2009
2010
2009
$
190
$
(94)
$
(1,301)
$
51
34
12
(51)
33
(114)
(82)
(23)
(73)
(1)
$
110
$
(165)
$
(1,375)
$
11
Three Months Ended
Nine Months Ended
September 30,
September 30,
2010
2009
2010
2009
1,519.8
1,509.3
1,517.0
1,507.0
9.5
7.4
1,529.3
1,509.3
1,517.0
1,514.4
Table of Contents
Three Months Ended
Percentage
September 30
Point
2010
2009
Increase (Decrease)
(113.6) %
97.0 %
128.9 %
(95.5) %
15.3 %
1.5 %
Nine Months Ended
Percentage
September 30
Point
2010
2009
Increase (Decrease)
(0.7) %
(30.8) %
30.1 %
20.9 %
49.1 %
(28.2) %
20.2 %
18.3 %
1.9 %
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Three Months Ended
Nine Months Ended
September 30,
September 30,
2010
2009
2010
2009
$
1,102
$
1,167
$
3,244
$
3,530
431
441
1,410
1,431
223
252
707
766
182
181
536
533
1,938
2,041
5,897
6,260
2
5
10
(22
)
(18
)
(98
)
(161
)
$
1,916
$
2,025
$
5,804
$
6,109
$
213
$
248
$
574
$
790
184
198
628
671
97
143
326
447
71
81
216
244
565
670
1,744
2,152
(59
)
(89
)
(238
)
(293
)
(103
)
(140
)
(358
)
(497
)
(23
)
(264
)
(1,771
)
(644
)
(129
)
(126
)
(381
)
(381
)
251
51
(1,004
)
337
(88
)
(95
)
(288
)
(298
)
$
163
$
(44
)
$
(1,292
)
$
39
Table of Contents
Table of Contents
September 30,
December 31,
2010
2009
$
30
$
29
3
4
480
480
61
64
$
574
$
577
Table of Contents
Table of Contents
Three Months Ended September 30,
in millions
2010
2009
$
190
$
(94
)
5
18
28
236
129
126
152
390
(25
)
(5
)
(21
)
$
296
$
291
Table of Contents
Nine Months Ended September 30,
in millions
2010
2009
$
(1,301
)
$
51
1,817
65
10
(250
)
17
(3
)
139
94
523
381
381
2,152
1,022
(93
)
(121
)
(21
)
(74
)
$
737
$
878
Table of Contents
Three Months Ended
Three Months Ended
(in millions)
September 30, 2010
September 30, 2009
U.S.
International
Total
U.S.
International
Total
$
280
$
126
$
406
$
314
$
131
$
445
82
62
144
90
73
163
$
362
$
188
$
550
$
404
$
204
$
608
Table of Contents
1
Table of Contents
Three Months Ended
Three Months Ended
(in millions)
September 30, 2010
September 30, 2009
U.S.
International
Total
U.S.
International
Total
$
68
$
43
$
111
$
106
$
139
$
245
131
64
195
116
50
166
59
59
199
166
365
222
189
411
11
20
31
14
27
41
$
210
$
186
$
396
$
236
$
216
$
452
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Change
Three Months Ended
As Reported
Constant
September 30,
Currency
Currency
in millions
2010
2009
Basis
Basis
$
1,102
$
1,167
(6)
%
(6)
%
395
438
(10)
%
(3)
%
234
243
(4)
%
(12)
%
185
175
6
%
1
%
814
856
(5)
%
(5)
%
1,916
2,023
(5)
%
(5)
%
0
2
N/A
N/A
$
1,916
$
2,025
(5)
%
(5)
%
Change
Nine Months Ended
As Reported
Constant
September 30,
Currency
Currency
in millions
2010
2009
Basis
Basis
$
3,244
$
3,530
(8)
%
(8)
%
1,305
1,353
(4)
%
(2)
%
707
726
(3)
%
(8)
%
544
491
11
%
1
%
2,556
2,570
(1)
%
(3)
%
5,800
6,100
(5)
%
(6)
%
4
9
N/A
N/A
$
5,804
$
6,109
(5)
%
(6)
%
Table of Contents
Change
Three Months Ended
As Reported
Constant
September 30,
Currency
Currency
in millions
2010
2009
Basis
Basis
$
550
$
608
(10)
%
(8)
%
614
682
(10)
%
(11)
%
167
164
2
%
2
%
781
846
(8)
%
(8)
%
36
38
(6)
%
(6)
%
79
85
(7)
%
(8)
%
269
260
4
%
4
%
122
114
7
%
6
%
391
374
5
%
5
%
79
72
9
%
9
%
1,916
2,023
(5)
%
(5)
%
0
2
N/A
N/A
$
1,916
$
2,025
(5)
%
(5)
%
Change
Nine Months Ended
As Reported
Constant
September 30,
Currency
Currency
in millions
2010
2009
Basis
Basis
$
1,615
$
1,806
(11)
%
(11)
%
1,961
2,155
(9)
%
(11)
%
498
493
1
%
0
%
2,459
2,648
(7)
%
(9)
%
111
112
(1)
%
(2)
%
248
259
(4)
%
(7)
%
794
737
8
%
7
%
354
333
6
%
5
%
1,148
1,070
7
%
6
%
219
205
6
%
6
%
5,800
6,100
(5)
%
(6)
%
4
9
N/A
N/A
$
5,804
$
6,109
(5)
%
(6)
%
Table of Contents
Q3
2010 Net Sales as compared to Q3
2009
Change
Estimated
As Reported
Constant
Impact of
Currency
Currency
Foreign
in millions
Basis
Basis
Currency
$
(58
)
$
(47
)
$
(11
)
(68
)
(73
)
5
3
3
0
(65
)
(70
)
5
(2
)
(2
)
0
(6
)
(7
)
1
9
9
0
8
7
1
17
16
1
7
7
0
(107
)
(103
)
(4
)
(2
)
(2
)
0
$
(109
)
$
(105
)
$
(4
)
Q3
2010 YTD Net Sales as compared to Q3
2009
Change
Estimated
As Reported
Constant
Impact of
Currency
Currency
Foreign
in millions
Basis
Basis
Currency
$
(191
)
$
(192
)
$
1
(194
)
(230
)
36
5
(2
)
7
(189
)
(232
)
43
(1
)
(2
)
1
(11
)
(17
)
6
57
50
7
21
17
4
78
67
11
14
13
1
(300
)
(363
)
63
(5
)
(5
)
0
$
(305
)
$
(368
)
$
63
Table of Contents
Three
Nine
Months
Months
68.9
%
69.4
%
(1.6
) %
(1.9
) %
(0.3
) %
(0.4
) %
0.5
%
(0.3
) %
(0.2
) %
67.5
%
66.6
%
Table of Contents
Three Months Ended September 30,
Nine Months Ended September 30,
2010
2009
2010
2009
% of Net
% of Net
% of Net
% of Net
(in millions)
$
Sales
$
Sales
$
Sales
$
Sales
634
33.1
665
32.8
1,897
32.7
1,987
32.5
230
12.0
258
12.7
714
12.3
778
12.7
39
2.0
51
2.5
147
2.5
149
2.4
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Total estimated amount expected to
Type of cost
be incurred
$205 million to $207 million
$31 million
$65 million
$66 million
$16 million to $18 million
$42 million to $48 million
$425 million to $435 million
(1)
(2)
Table of Contents
Total estimated amount expected to
Type of cost
be incurred
$30 million to $35 million
$20 million to $25 million
$85 million to $90 million
$135 million to $150 million
(1)
Table of Contents
Total estimated amount expected
Type of Cost
to be incurred
$110 million to $115 million
$5 million to $10 million
$45 million to $50 million
$20 million to $25 million
$180 million to $200 million
(1)
(2)
Termination
Retention
Accelerated
Transfer
Fixed Asset
(in millions)
Benefits
Incentives
Depreciation
Costs
Write-offs
Other
Total
$
2
$
1
$
2
$
5
$
2
$
10
12
1
1
2
10
1
13
$
2
$
2
$
10
$
1
$
3
$
18
Termination
Retention
Accelerated
Transfer
Fixed Asset
(in millions)
Benefits
Incentives
Depreciation
Costs
Write-offs
Other
Total
$
2
$
1
$
3
$
6
2
$
2
$
8
12
(2
)
2
-
$
2
$
2
$
10
$
1
$
3
$
18
Table of Contents
Termination
Retention
Accelerated
Transfer
Fixed Asset
(in millions)
Benefits
Incentives
Depreciation
Costs
Write-offs
Other
Total
$
4
$
3
$
2
$
9
$
1
$
3
$
9
13
3
2
5
1
1
5
5
9
19
$
4
$
5
$
5
$
9
$
3
$
2
$
28
Termination
Retention
Accelerated
Transfer
Fixed Asset
(in millions)
Benefits
Incentives
Depreciation
Costs
Write-offs
Other
Total
$
2
$
2
$
3
$
7
2
$
5
3
6
$
3
$
2
21
$
4
$
5
$
5
$
9
$
3
$
2
$
28
Termination
Retention
Accelerated
Transfer
Fixed Asset
(in millions)
Benefits
Incentives
Depreciation
Costs
Write-offs
Other
Total
$
66
$
8
$
24
$
98
$
6
$
32
38
3
3
6
32
3
41
$
66
$
6
$
32
$
8
$
27
$
139
Termination
Retention
Accelerated
Transfer
Fixed Asset
(in millions)
Benefits
Incentives
Depreciation
Costs
Write-offs
Other
Total
$
61
$
8
$
23
$
92
4
$
6
$
20
30
1
12
4
17
$
66
$
6
$
32
$
8
$
27
$
139
Termination
Retention
Accelerated
Transfer
Fixed Asset
(in millions)
Benefits
Incentives
Depreciation
Costs
Write-offs
Other
Total
$
25
$
6
$
13
$
44
$
4
$
7
$
25
36
9
2
11
3
3
16
9
25
50
$
25
$
16
$
9
$
25
$
6
$
13
$
94
Table of Contents
Termination
Retention
Accelerated
Transfer
Fixed Asset
(in millions)
Benefits
Incentives
Depreciation
Costs
Write-offs
Other
Total
$
19
$
5
$
8
$
32
6
$
16
4
17
$
6
$
13
62
$
25
$
16
$
9
$
25
$
6
$
13
$
94
2010
Plant
2007
Restructuring
Network
Restructuring
(in millions)
Plan
Optimization
Plan
Total
$
61
$
26
$
205
$
292
8
31
39
20
65
85
89
26
301
416
66
66
12
16
28
32
41
73
3
3
3
44
123
170
$
92
$
70
$
424
$
586
Table of Contents
2010
Plant
2007
Restructuring
Network
Restructuring
(in millions)
Plan
Optimization
Plan
Total
$
19
$
19
$
8
$
2
10
3
3
$
22
$
8
$
2
$
32
$
33
$
12
$
45
2
2
$
20
12
32
15
3
18
$
48
$
20
$
29
$
97
$
33
$
191
$
224
66
66
$
32
41
73
15
64
79
$
48
$
32
$
362
$
442
Table of Contents
Three Months Ended
Nine Months Ended
Sept 30,
September 30,
(in millions)
2010
2009
2010
2009
$
3
$
1
$
12
$
6
3
(1
)
(8
)
(4
)
(3
)
(4
)
(6
)
(15
)
$
3
$
(4
)
$
(2
)
$
(13
)
*
Table of Contents
Table of Contents
Nine Months Ended
September 30,
(in millions)
2010
2009
$
(124)
$
1,164
(217)
(733)
101
(693)
Table of Contents
Payments due by Period
(in millions)
2010
2011
2012
2013
2014
Thereafter
Total
$
100
$
200
$
700
$
1,000
850
$
600
$
3,600
5,050
$
950
$
200
$
700
$
600
$
3,600
$
6,050
Note:
The table above does not include discounts
associated with our senior notes, or amounts related
to certain interest rate swaps that were used to
hedge the fair value of certain of our senior notes.
Current
Actual as of
Requirement
September 30, 2010
3.85 times
2.6 times
3.0 times
5.7 times
(1)
(2)
Table of Contents
September 30,
December 31,
(in millions)
2010
2009
$
904
$
3
5,133
5,915
6,037
5,918
624
864
$
5,413
$
5,054
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
84
85
OTHER INFORMATION
Table of Contents
Table of Contents
86
BOSTON SCIENTIFIC CORPORATION
By:
/s/ Jeffrey D. Capello
Name:
Jeffrey D. Capello
Title:
Executive Vice President and
Chief Financial Officer
PARTICIPANT: | ||||||
|
||||||
|
Signature | |||||
|
|
|||||
|
||||||
BOSTON SCIENTIFIC CORPORATION | ||||||
|
||||||
J. Raymond Elliott | ||||||
President and Chief Executive Officer |
Percent of | ||
Stock Option | Date Vested | |
25% | Month dd, yyyy | |
25% | Month dd, yyyy | |
25% | Month dd, yyyy | |
25% | Month dd, yyyy |
PARTICIPANT: | ||||||
|
||||||
|
Signature | |||||
|
|
|||||
|
||||||
BOSTON SCIENTIFIC CORPORATION | ||||||
|
||||||
J. Raymond Elliott | ||||||
President and Chief Executive Officer |
BOSTON SCIENTIFIC FUNDING LLC
|
||||
By: | ||||
Name: | Milan Kofol | |||
Title: | Treasurer | |||
BOSTON SCIENTIFIC CORPORATION,
as Servicer and Seller |
||||
By: | ||||
Name: | Milan Kofol | |||
Title: | Vice President, Treasurer |
OLD LINE FUNDING, LLC
BY: ROYAL BANK OF CANADA, ITS ATTORNEY-IN-FACT |
||||
By: | ||||
Name: | ||||
Title: | ||||
ROYAL BANK OF CANADA, individually as a Liquidity Bank, as Old Line Agent and as Administrative Agent |
||||
By: | ||||
Name: | ||||
Title: | ||||
By: | ||||
Name: | ||||
Title: |
VICTORY RECEIVABLES CORPORATION |
||||
By: | ||||
Name: | ||||
Title: | ||||
THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH, as a Liquidity Bank |
||||
By: | ||||
Name: | ||||
Title: | ||||
THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.,
NEW YORK BRANCH, as Victory Agent |
||||
By: | ||||
Name: | ||||
Title: |
LIBERTY STREET FUNDING LLC |
||||
By: | ||||
Name: | ||||
Title: | ||||
THE BANK OF NOVA SCOTIA, as a Liquidity Bank
|
||||
By: | ||||
Name: | ||||
Title: | ||||
THE BANK OF NOVA SCOTIA, as Liberty Street Agent |
||||
By: | ||||
Name: | ||||
Title: |
1. | I have reviewed this Quarterly Report on Form 10-Q of Boston Scientific Corporation; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; | |
4. | The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | ||
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | ||
c) | Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | ||
d) | Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
5. | The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and | ||
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
Date: November 5, 2010 | /s/ J. Raymond Elliott | |||
J. Raymond Elliott | ||||
President and Chief Executive Officer |
1. | I have reviewed this Quarterly Report on Form 10-Q of Boston Scientific Corporation; | |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; | |
4. | The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | ||
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | ||
c) | Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | ||
d) | Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
5. | The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and | ||
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
Date: November 5, 2010 | /s/ Jeffrey D. Capello | |||
Jeffrey D. Capello | ||||
Executive Vice President and
Chief Financial Officer |
(1) | the Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and | ||
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation. |
By: | /s/ J. Raymond Elliott | |||
J. Raymond Elliott | ||||
President and Chief Executive Officer |
(1) | the Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and | ||
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation. |
By: | /s/ Jeffrey D. Capello | |||
Jeffrey D. Capello | ||||
Executive Vice President and
Chief Financial Officer |